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A delayed rectiﬁer voltage-gated K+ channel (Kv) represents the largest ionic conductance of
plateletsandmegakaryocytes,butisundeﬁnedatthemolecularlevel.QuantitativeRT-PCRofall
known Kv α and ancillary subunits showed that only Kv1.3 (KCNA3) is substantially expressed
i nh u m a np l a t e l e t s .F u r t h e r m o r e ,m e g a k a r y o c y t e sf r o mK v 1 . 3 −/− mice or from wild-type
mice exposed to the Kv1.3 blocker margatoxin completely lacked Kv currents and displayed
substantiallydepolarisedrestingmembranepotentials.Inhumanplatelets,margatoxinreduced
the P2X1- and thromboxaneA2 receptor-evoked [Ca2+]i increases and delayed the onset of
store-operated Ca2+ inﬂux. Megakaryocyte development was normal in Kv1.3−/− mice, but the
platelet count was increased, consistent with a role of Kv1.3 in apoptosis or decreased platelet
activation.WeconcludethatKv1.3formstheKvchanneloftheplateletandmegakaryocyte,which
sets the resting membrane potential, regulates agonist-evoked Ca2+ increases and inﬂuences
circulating platelet numbers.
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Introduction
Ion channels are a large and diverse family of trans-
membrane proteins that play important roles in all
cell types. Their functions in the platelet are poorly
understood (reviewed in Mahaut-Smith, 2004), although
it is clear from patch clamp studies of platelets and
megakaryocytes that the largest amplitude ionic currents
are conducted through voltage-gated K+-selective (Kv)
channels (Maruyama, 1987; Kawa, 1990; Kapural et al.
1995; Romero & Sullivan, 1997). These channels activate
on depolarisation to potentials positive to −60mV, are
steeply voltage dependent over the range −40 to −10mV
and are maximally activated at potentials above 0mV
(Maruyama, 1987). They open and close with a relatively
slow timecourse and are therefore comparable to the
‘delayed rectiﬁer’ K+ channels of excitable tissues that
contribute to action potential repolarisation. In the
platelet, this K+ conductance could serve to stabilise
the membrane potential at rest or following inﬂux of
Ca2+ or Na+ through agonist-evoked channels such
as Orai1, P2X1 and TRPC6 (Varga-Szabo et al. 2009).
Voltage-dependent K+ channels also play crucial roles in
volume regulation and cell proliferation of lymphocytes
(Lewis&Cahalan,1995;Chandyetal.2004).However,the
molecularcompositionofthevoltage-gatedK+channel(s)
in platelets, and their precursor cell the megakaryocyte,
is unknown. Pharmacological studies (Maruyama, 1987;
Kawa, 1990; Romero & Sullivan, 1997) indicate that one
or more members of the Kv1 or Kv3 families could
contribute, as reported for lymphocytes (Grissmer et al.
1992; Lewis & Cahalan, 1995). Here we show for the ﬁrst
time that the voltage-gated K+ channel of the platelet
and megakaryocyte is formed by Kv1.3 subunits, with no
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evidence for a signiﬁcant contribution from K+ channel
subunits of other Kv families. We also show that the
channel is not essential for megakaryocyte development,
but that it inﬂuences the number of circulating platelets
and promotes agonist-evoked increases in intracellular
Ca2+, a key second messenger during platelet-dependent
thrombosis.
Methods
Materials and salines
Standard external saline contained (in mM): 145 NaCl, 5
KCl, 1 CaCl2,1M g C l 2,1 0H e p e s ,1 0D-glucose, pH7.35
with NaOH. CaCl2 was omitted for nominally Ca2+-free
saline. The patch pipette saline contained (in mM): 150
KCl, 2 MgCl2,1 0H e p e s ,1 0D-glucose, pH 7.2 with
KOH. Acid citrate dextrose (ACD) contained (in mM):
85 trisodium citrate, 78 citric acid, 111 glucose. Fura-2
wasfromMolecularProbes-Invitrogen(theNetherlands).
Margatoxin and apyrase (type VII) were from Sigma
(Poole, Dorset, UK).
Cell source and preparation
Marrow was removed from the femoral and tibial
marrow of C57/bl6 or Kv1.3−/− mice by ﬂushing with
standard saline containing 0.32Uml−1 apyrase. For
immunohistochemical studies, clumps of marrow were
immediately frozen in Tissue-Tek
R   O.C.T.TM compound
(Sakura, the Netherlands). For electrophysiological
recordings, marrow was gently triturated to disperse the
cells and maintained on a rotor at room temperature for
usewithin12h.ThegenerationofKv1.3−/− mice(C57bl/6
background) has been described previously (Koni et al.
2003); control mice (bred in-house at the University of
Leicester or from Charles River, UK) were matched for
age and sex. For studies of human platelets, standard
phlebotomy techniques were used to draw blood from
informed, consenting donors according to a protocol
approved by the local ethics committees of the University
of Leicester and the University of Lund. For intracellular
Ca2+measurements,bloodwasanti-coagulatedwithACD,
platelet-rich plasma (PRP) prepared by centrifugation at
700g for 5min and washed platelet suspensions prepared
bycentrifugationat350g for20min.Plateletsweretreated
with aspirin (100μM) and apyrase (0.32Uml−1). For
cDNA preparation, whole human blood was collected
into ACD supplemented with 2mM EDTA, 0.1μM PGE1
and 300μM aspirin as described elsewhere (Amisten et al.
2008). Mouse blood was withdrawn into ACD by cardiac
puncture under terminal gaseous anaesthesia according
to UK Home Ofﬁce guidelines. All procedures within this
studywereperformedinaccordancewithethicalstandards
as outlined in Drummond (2009).
Intracellular Ca2+ measurements
Ratiometric Ca2+ measurements from washed
suspensions of fura-2-loaded platelets were conducted as
described in detail previously (Rolf et al. 2001) using a
Cairn cuvette spectrophotometer (Cairn Research Ltd,
Faversham, UK). Platelets were loaded with fura-2 by
incubation of PRP with 2μM fura-2AM for 45min at
37◦C and initially resuspended in nominally Ca2+-free
saline in the presence of apyrase (0.32Uml−1). CaCl2 was
a d d e dt oo b t a i ne x t e r n a lC a 2+ as required by the speciﬁc
protocol. Fura-2 was calibrated extracellularly using a
Kd of 224nM following release by digitonin (50μM)
and determination of Rmin and Rmax values in Ca2+-free
(10mM EGTA) or Ca2+-containing (2mM CaCl2) salines
at neutral pH. All fura-2 recordings were corrected for
background ﬂuorescence, determined by quenching with
MnCl2.
Patch clamp recordings
Conventional whole-cell patch clamp recordings were
conducted using an Axopatch 200B, as described in detail
elsewhere (Mahaut-Smith, 2004). Megakaryocytes were
identiﬁed by their large size and multilobed nucleus
(Mahaut-Smith, 2004). For voltage clamp recordings,
series resistance (Rs) compensation of ≥70% was
applied. Whole-cell capacitance, which is a quantitative
measurement of the megakaryocyte platelet-generating
demarcation membrane system (Mahaut-Smith et al.
2003), was read directly from the patch clamp ampliﬁer
following compensation of the current transients evoked
by a 5mV voltage step from −80mV, a potential range
that does not activate voltage-gated channels in these cells
(Mahaut-Smith et al. 2003; Mahaut-Smith, 2004).
Platelet counting
MurineplateletsinACD-anticoagulatedwholebloodwere
counted by ﬂow cytometry according to the method
developed by Alugupalli et al. (2001). Brieﬂy, platelets
were labelled with a FITC-conjugated anti-CD41 anti-
body (BD Pharmingen; 1 in 300 dilution) for 1h and
counted at a ﬁnal dilution of >1000 in Ca2+-free
(1mM EGTA) standard platelet saline in the presence
of 5.5μm diameter ﬂuorescent beads of known density
(SPHERO ACFP-50-5, Spherotech, Lake Forest, IL, USA).
Fluorescence was measured at low rate in a single channel
(488nmexcitation)ofaFACSCaliburﬂowcytometer(BD
Biosciences), which provided clear separation of platelets,
beads and unlabelled cells (see online Supplementary
ﬁgure). The platelet count was calculated from the ratio
of beads to platelets, the dilution factor,and the densityof
beads.
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cDNA generation and quantitative PCR
Platelets were puriﬁed and cDNA was generated as
described elsewhere (Amisten et al. 2008). qPCR was
performed using Quantifast SYBR Green PCR kit
and QuantiTect Primer Assays (Qiagen, Venlo, the
Netherlands) in a Roto-Gene 2000 thermal cycler
(Corbett Life Science, NSW, Australia) according to
the manufacturers’ instructions. Gene expression was
calculated according to the   Ct method with GAPDH
as a reference (Pfafﬂ, 2009).
Megakaryocyte size distribution
Sections 12μm thick were cut from clumps of marrow
frozen in Tissue-Tek
R   O.C.T.TM compound and
thaw-mounted on slides. Sections were incubated in
FITC-conjugated rat antimouse CD41 monoclonal anti-
body (BD Pharmingen) for 1h and washed prior to
analysis on an Olympus IX81 FV1000 confocal micro-
scope. Fluorescence images (488nm excitation, >500nm
emission) were acquired of randomly selected 0.1mm2
ﬁ e l d so fv i e w( s i xf r o me a c ho f7W Ta n d7K v 1 . 3 −/−
mice). Olympus FV1000 analysis software was used to
draw around the periphery of stained cells and thus to
compute megakaryocyte area.
Statistics
Statistical signiﬁcance was assessed using either Student’s
t test (paired for intracellular Ca2+ recordings and
unpaired for membrane capacitance, megakaryocyte size
distribution and platelet count) or one-way analysis of
variance (membrane potential). Signiﬁcance is indicated
at levels of 0.05 (∗), 0.01 (∗∗), 0.005 (∗∗∗) or 0.001 (∗∗∗∗).
Figure 1. Kv1.3 forms the voltage-gated K+ channel of human platelets and murine megakaryocytes
A, expression of Kv subunits relative to GAPDH in human platelets. Of all 51 known Kv subunits (see Supplementary
information) only three (KCNA3, KCNAB2 and KCNE3) were detected by quantitative PCR at levels above back-
ground. B and C, typical whole-cell currents (B) and average peak current densities (C) in response to 3 s duration
voltage steps from −80 mV to potentials in the range −120 to 60 mV (see voltage protocol in B) for wild-type
(WT) megakaryocytes, Kv1.3-deﬁcient megakaryocytes (Kv1.3−/−) and WT megakaryocytes after 10 min exposure
to 10 nM margatoxin (mgtx).
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Results and Discussion
To identify components of the voltage-dependent K+
conductance of the human platelet, we used real-time
PCR to screen puriﬁed platelet cDNA for transcripts of
Figure 2. Kv1.3 is the major determinant of the membrane
potential in mouse megakaryocytes
A, current clamp recording of membrane potential in a wild type
megakaryocyte during exposure to 10 nM margatoxin (mgtx). B,
average membrane potential in wild-type megakaryoctyes in the
presence and absence of margatoxin at the times indicated after
transition to whole-cell recording, and in Kv1.3−/− megakaryocytes.
C, time-course of block of voltage-gated K+ currents by 10 nM
margatoxin in 4 different wild-type megakaryocytes.
all known α (pore-forming) and β or other ancillary
subunits of the Kv family of ion channels (51 targets,
see Supplementary Table 1). A single α subunit trans-
c r i p tw a sd e t e c t e d ,f o rt h eg e n eKCNA3,w h i c he n c o d e s
Kv1.3.TheonlyothersubunitsdetectedwereforKCNAB2
andKCNE3 (whichencodeKvβ2andMirp2,respectively),
b u tb o t hw e r ee x p r e s s e da te x t r e m e l yl o wl e v e l s( <1%
of Kv1.3; Fig.1A). The primary megakaryocyte is an
authentic surrogate for electrophysiological studies of
the small and fragile platelet (Tolhurst et al. 2005),
therefore we used whole-cell patch clamp to investigate
Kv currents of megakaryocytes from wild-type and
Kv1.3-deﬁcient mice. Using pseudophysiological internal
andexternalsalines,voltagestepsfromaholdingpotential
of −80mV activated a large transient outward current
at potentials positive to about −40mV in wild-type
megakaryocytes (Fig.1B top panel and Fig.1C), with
a mean magnitude of 11.8±1.0nA at 0mV (n=14).
This voltage-gated outward current was totally absent in
Kv1.3-deﬁcient megakaryocytes (Fig.1B centre panel and
Fig.1C), consistent with the quantitative PCR screen and
implies that this channel is a homomultimer of Kv1.3.
In contrast to murine lymphocytes (Koni et al. 2003),
we failed to detect any compensatory anion currents in
more than 30 recordings from Kv1.3−/− megakaryocytes.
Margatoxin (10nM) is a relatively selective inhibitor of
Kv1.3 (Chandy et al. 2004; Gutman et al. 2005) and this
blocked the outward currents (Fig.1B lower panel and
Fig.1C), further supporting the conclusion that Kv1.3
channels mediate the voltage-gated K+ conductance of
the megakaryocyte and platelet.
In whole-cell current clamp recordings, the
average membrane potential (Vm) of unstimulated
megakaryocytes from wild-type mice was −46.6±2mV ,
n=7( F i g . 2 B), around which regular spontaneous
ﬂuctuations of ∼2–3mV were observed (see sample
recording in Fig. 2A). Margatoxin (10nM)s l o w l y
depolarised this resting potential over a timecourse that
varied between cells (see, for example, Fig.2A), taking
between4and8mintoreachastableVm of−14.7±3mV
(n=7;P <0.001;Fig.2B).Asimilarrangeoftimecourses
was observed for the block of voltage-dependent
outward currents by 10nM margatoxin in voltage
clamp experiments (Fig.1C). The margatoxin-induced
depolarisation was slowly, and only partially, reversible
(notshown),consistentwiththeslowwash-off(>20min)
reported previously for this toxin (Garcia-Calvo et al.
1993). However, the depolarisation caused by margatoxin
was speciﬁcally related to block of Kv1.3 as there
was no signiﬁcant loss of membrane potential during
the ﬁrst 8min of whole-cell recording in untreated
wild-type megakaryocytes (−43.9±0.9mV, P >0.05;
Fig.2B). The Vm of Kv1.3-deﬁcient megakaryocytes
was also substantially depolarised, on average to
−10±2mV (n=5; P <0.001, Fig.2B), further
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supporting a major role for this channel in the resting
potential.
Kv1.3 may inﬂuence platelet activation by increased
agonist-evoked Ca2+ inﬂux, through maintenance of the
initial driving force for Ca2+ entry; furthermore, inﬂux of
cations will substantially depolarise the cell if counter-ion
movement is not provided. In fura-2-loaded human
platelets, margatoxin signiﬁcantly reduced the peak Ca2+
increase following stimulation of P2X1 (1μM αβmeATP)
and thromboxaneA2 (500nM U46619) receptors to
62±10% and 76±8% (P <0.05) of control,respectively
(Fig.3A). In addition, margatoxin delayed the initial
phase of store-operated Ca2+ inﬂux, tested by addition
of external Ca2+ after 10min exposure to thapsigargin.
The [Ca2+]i increase stimulated after 10s was reduced
to 69 ±8% (P <0.05) of control; however, there was
no signiﬁcant effect on the peak Ca2+ increase (Fig.3B).
Together, these results suggest that Kv1.3 promotes early
Ca2+ inﬂux through multiple pathways stimulated during
platelet activation, including P2X1 ionotropic receptors
a n ds t o r e - o p e r a t e dC a 2+ channels. An increase in [Ca2+]i
isakeysignalduringplateletactivation(Varga-Szaboetal.
2009) and in vivo studies have demonstrated important
rolesforP2X1andOrai1store-operatedCa2+channelsub-
unitsinarterialthrombosis.Thus,Kv1.3mayalsofacilitate
haemostasis and thrombosis; however, further work is
required to address this issue. Direct interactions between
Kv channels and integrins have been described in several
celltypes,includinglymphocytes(Leviteetal.2000);thus,
Kv1.3 may inﬂuence platelet aggregation and adhesion
independently of effects on intracellular Ca2+. Additional
studies are also required to determine which other
channels act as counter-ion pathways for Ca2+ inﬂux in
the absence of Kv1.3; however, intermediate conductance
Ca2+-activated K+ channels previously reported in
human platelets are a likely candidate (Mahaut-Smith,
1995).
A role for Kv channels in thymocyte development
has been described (Freedman et al. 1995), but no
differences could be detected between Kv1.3−/− and
age/sex-matched wild-type mice in the size distribution
(Fig.4A; P >0.05) of bone marrow megakaryocytes,
suggesting that megakaryocytedevelopment is normal. In
addition, the high speciﬁc membrane capacitance of the
Figure 3. Role for Kv1.3 in human platelet Ca2+ signalling
A and B,t y p i c a l( a) and average (b)[ C a 2+]i responses in fura-2-loaded washed human platelet suspensions in the
presence and absence of 10 nM margatoxin (mgtx). A. Responses following activation of P2X1 and thromboxane
A2 receptors by αβmeATP (1 μM) and U46619 (500 nM), respectively. B, store-operated [Ca2+]i increases induced
by addition of CaCl2 (0.25 mM) after 10 min in 1 μM thapsigargin; [Ca2+]i increases were measured after 10 s and
at the peak of the response.
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megakaryocyte,whichreﬂectstheamountofdemarcation
membrane system (Mahaut-Smith et al. 2003), was
unaffected by loss of Kv1.3 (8.19±0.24μFcm −2 for
WT and 7.98±0.42μFcm −2 for Kv1.3−/−, P >0.05;
Fig.4B). This plasma membrane invagination system
provides the additional membrane required for the
process of thrombopoiesis (Schulze et al. 2006); therefore
these data indicate that the platelet-generating capacity
of the megakaryocyte is normal in Kv1.3−/− mice. In
contrast, platelet counts were signiﬁcantly increased in
Kv1.3−/− mice compared to control mice (1.47×106 vs.
1.12×106 μl−1; n=7, P <0.005; Fig.4C). The under-
lying basis of this increased platelet count is unknown
and currently under investigation. One possibility is the
role of mitochondrial Kv1.3 channels in apoptosis, as
recentlydescribedinlymphocytes(Szaboetal.2008),since
plateletlifespaniscontrolledbyanintrinsicprogrammeof
apoptosis (Mason et al. 2007). Alternatively, the reduced
Ca2+ responses of Kv1.3-deﬁcient platelets may decrease
activation and thereby increase survival of circulating
platelets. This is opposite to the situation in mice that
express a constitutively active Stim1 mutant, whose
platelets have elevated cytosolic Ca2+ levels and shorter
circulationlife-timeleadingtothrombocytopenia(Grosse
et al. 2007).
In conclusion, this study demonstrates for the ﬁrst
time that Kv1.3 channels are responsible for the major
K+ conductance and the resting potential of the
platelet. Consequently, blockade of Kv1.3 reduces Ca2+
entry through a number of different agonist-stimulated
pathways. Kv1.3 is known to play roles in immune
responses, olfaction and glucose homeostasis (Fadool
et al. 2004; Xu et al. 2004; Cahalan & Chandy, 2009)
and proposed as a target for treatment of multiple
sclerosis(Rangarajuetal.2009).Thepresentstudyextends
the roles of Kv1.3 to the platelet where it inﬂuences
the membrane potential, Ca2+ responses and circulating
platelet numbers.
Figure 4. Role for Kv1.3 in platelet count, but not megakaryocyte development
A, megakaryocyte size distribution in marrow from wild-type and Kv1.3-deﬁcient mice; Aa, sample sections stained
with a FITC-conjugated anti-CD41 antibody, and Ab, frequency histogram of different size megakaryocytes,
which showed no signiﬁcant differences (P > 0.05) across the range of sizes. B, speciﬁc membrane capacitance
measurement of the demarcation membrane system in Kv1.3−/− and wild-type megakaryocytes (n = 23 and 61,
respectively; P > 0.05). C, platelet count in wild-type and Kv1.3-deﬁcient mice (n = 7).
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